Jump to main content
Jump to site search

Issue 6, 2015
Previous Article Next Article

New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies

Author affiliations

Abstract

We report the synthesis and pharmacological characterization of a new series of adenosine derivatives on the four adenosine receptors (ARs). In radioligand binding assays, some of the compounds (1, 4, 6 and (R)-6) display a potent affinity for the A2AAR (Ki values < 10 nM) with high A1/A2A and A2B/A2A selectivity, moderate for the A3AR and low for the A1AR. The affinity of the epimeric mixture 6 was similar to that of the corresponding (R)-6 stereoisomer and 10-fold higher than that of the (S)-6 stereoisomer. The phenylethylamino group appears to play a key role on the activity, but introduction of groups of different sizes and electronegativity does not induce a substantial change in affinity for the A2AAR. In functional assays, most of the compounds produced similar amounts of cAMP compared to NECA, thus behaving as full A2AAR agonists. In addition, compounds 1, 2, 3, 5, (S)-6 and 9 resulted to be good antagonists for A3AR with KB in the 6–14 nM range. Docking studies on the A2AAR showed a conserved binding mode consistent with previous A2AAR agonist-bound crystal structures, allowing for a rational interpretation of the SAR of this compound series.

Graphical abstract: New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Feb 2015, accepted on 12 May 2015 and first published on 13 May 2015


Article type: Concise Article
DOI: 10.1039/C5MD00086F
Author version
available:
Download author version (PDF)
Citation: Med. Chem. Commun., 2015,6, 1178-1185
  •   Request permissions

    New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies

    A. Rodríguez, A. Guerrero, H. Gutierrez-de-Terán, D. Rodríguez, J. Brea, M. I. Loza, G. Rosell and M. Pilar Bosch, Med. Chem. Commun., 2015, 6, 1178
    DOI: 10.1039/C5MD00086F

Search articles by author

Spotlight

Advertisements